Health4 years ago
Johnson & Johnson’s Covid-19 vaccine evoked an immune response in early-stage studies
Johnson & Johnsonof JNJ 0.61% The Covid-19 vaccine elicited an immune response in most people who received injections in a small initial trial and showed...
Recent Comments